Effectual Strategies for Prevention, Diagnosis and Therapy


The Journal of Molecular Oncology Research relies on the efforts and benevolence of the reviewers on assessing the suitability of a manuscript for publication The Journal of Molecular Oncology Research. The inputs of reviewers are frequently used in improving the quality of a submitted manuscript. The reviewing of a manuscript is very essential to assure the quality of the manuscript published in any journal. I thank all reviewers for their excellent contributions.

The completion of the human genome project, also because the contemporary availability of novel and powerful technologies with in genomics, proteomics and genomics promise to possess a serious impact on clinical practice, as these evolution are likely to vary the way during which cancer are going to be diagnosed, treated and monitored within the future.

Alongside major breakthroughs in our knowledge of the molecular mechanisms underlying the multistage nature of carcinogenesis, the targeted genes, their products and function(s), and therefore the signal ling avenue relevant to human cancer, these developments offer amazing opportunities to enhance cancer care by providing new and further effectual strategies for prevention, diagnosis and therapy.

At the moment we experience a get larger tendency in cancer research to form use of complex biological samples, and it's becoming increasingly clear that the appeal request of a more holistic approach could also be necessary so as to achieve a full understanding of the biology underlying the pathogenesis of this diseases.

 A multidisciplinary approach to cancer research would require the coordination of basic research activities and enormous resources and infrastructures, additionally to the creation of integrated and interdisciplinary environments with the participation of all the stakeholders within the cancer continuum: i.e. basic researchers, surgeons, oncologists, pathologists, epidemiologists, regulatory agencies and authorities, science policy makers, funding agencies, industry, advocacy groups, and society as an entire .

The Journal will publish original articles, reviews, technical notes, editorials, news and views (commentaries, science policy issues, ethical and legal issues, patient organizations, industry needs and alliances, regulatory issues, etc.), and letters to the editor.

The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded online at Editorial Tracking System (https://www.longdom.org/editorial-tracking/publisher.php) or forwarded to the Editorial Office at  https://www.longdom.org/eye-diseases-and-disorders.html

 The Journals includes around 150Abstracts and 100 Keynote speakers have given their valuable words. The meet has provided a great scope for interaction of professionals including in addition to clinical experts and top-level pathologists and scientists from around the globe, on a single platform.

Media Contact:
Managing Editor

Journal of Molecular Oncology Research
Email: oncology@openaccessjournal.org
Watsapp:+ +44-1470-490003